Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoniou

Showing results (191-200 of 395) with videos related to

Pageof 40
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2015
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomesZ Kote-Jarai, C Mikropoulos, D A Leongamornlert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2025
Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2Elizabeth A Loehrer, Frederieke H van der Baan, Thea M Mooij, et al.
Journal of Medical Genetics|April 10, 2019
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA reportAmanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, et al.
Journal of Medical Genetics|October 21, 2024
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based studyLucy Loong, Catherine Huntley, Joanna Pethick, et al.
Journal of Medical Genetics|November 21, 2022
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: <i>RAD51C</i>, <i>RAD51D</i>, <i>BRIP1</i> and <i>PALB2</i>Helen Hanson, Anjana Kulkarni, Lucy Loong, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
Cancers|May 21, 2020
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and PreventionFaiza Gaba, Oleg Blyuss, Xinting Liu, et al.
Archives of Dermatological Research|September 22, 2010
Definition of treatment goals for moderate to severe psoriasis: a European consensusU Mrowietz, K Kragballe, K Reich, et al.
British Journal of Cancer|November 12, 2025
Breast cancer risk prediction with a modified BOADICEA model in Danish womenSif Ingibergsdóttir Novitski, Rikke Louise Jacobsen, Timo Röder, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Pageof 40

Showing results (191-200 of 395) with videos related to

Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2015
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomesZ Kote-Jarai, C Mikropoulos, D A Leongamornlert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2025
Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2Elizabeth A Loehrer, Frederieke H van der Baan, Thea M Mooij, et al.
Journal of Medical Genetics|April 10, 2019
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA reportAmanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, et al.
Journal of Medical Genetics|October 21, 2024
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based studyLucy Loong, Catherine Huntley, Joanna Pethick, et al.
Journal of Medical Genetics|November 21, 2022
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: <i>RAD51C</i>, <i>RAD51D</i>, <i>BRIP1</i> and <i>PALB2</i>Helen Hanson, Anjana Kulkarni, Lucy Loong, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
Cancers|May 21, 2020
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and PreventionFaiza Gaba, Oleg Blyuss, Xinting Liu, et al.
Archives of Dermatological Research|September 22, 2010
Definition of treatment goals for moderate to severe psoriasis: a European consensusU Mrowietz, K Kragballe, K Reich, et al.
British Journal of Cancer|November 12, 2025
Breast cancer risk prediction with a modified BOADICEA model in Danish womenSif Ingibergsdóttir Novitski, Rikke Louise Jacobsen, Timo Röder, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Pageof 40